Category: Diagnostics


Lilly Shows Interest in Alzheimer’s Diagnostics 
Posted on Nov 08, 2010

Today we learn that Lilly is acquiring Avid Radiopharmaceuticals: Lilly will acquire all outstanding shares of Avid for an upfront payment of $300 million, subject to adjustment based on existing cash on hand at closing. Avid stockholders will also be eligible for up to $500 million in additional payments contingent upon potential future regulatory and commercial milestones for florbetapir.

Google Plus   Facebook   Twitter
Powered By : Supra International Inc.